RODSHEL NISANOV: Open Payments
NPI 1356005425 · FLUSHING, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,027 in 50 payments from 10 companies in 2025. Trend: 2023 $1,400 · 2024 $2,332 · 2025 $2,027
Food & beverage: $2,027
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 9 | $423 |
| Galderma Laboratories, L.P. | 2 | $398 |
| ABBVIE INC. | 9 | $347 |
| GENZYME CORPORATION | 4 | $230 |
| LEO Pharma Inc. | 14 | $227 |
| UCB, Inc. | 2 | $152 |
| Organon LLC | 4 | $101 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| Janssen Biotech, Inc. | 1 | $37 |
| PFIZER INC. | 1 | $29 |
Products named: Opzelura, NEMLUVIO, SKYRIZI, DUPIXENT, Bimzelx, ANZUPGO, VTAMA, COSENTYX.
Industry payments across NY — which companies pay providers there.
